BNP Paribas Financial Markets cut its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 92.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,060 shares of the business services provider's stock after selling 50,907 shares during the quarter. BNP Paribas Financial Markets' holdings in Cross Country Healthcare were worth $74,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. ABC Arbitrage SA acquired a new stake in shares of Cross Country Healthcare in the 4th quarter worth $3,038,000. Ieq Capital LLC acquired a new stake in shares of Cross Country Healthcare in the 4th quarter worth $231,000. Wolverine Asset Management LLC acquired a new stake in shares of Cross Country Healthcare in the 4th quarter worth $1,109,000. Olympiad Research LP acquired a new stake in shares of Cross Country Healthcare in the 4th quarter worth $1,520,000. Finally, Plato Investment Management Ltd acquired a new stake in shares of Cross Country Healthcare in the 4th quarter worth $46,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.
Cross Country Healthcare Stock Performance
Shares of Cross Country Healthcare stock traded up $0.11 on Thursday, hitting $12.95. The company's stock had a trading volume of 287,342 shares, compared to its average volume of 580,946. Cross Country Healthcare, Inc. has a 1 year low of $9.58 and a 1 year high of $18.50. The firm has a fifty day moving average price of $13.91 and a 200-day moving average price of $15.70. The company has a market capitalization of $424.54 million, a price-to-earnings ratio of -258.95, a price-to-earnings-growth ratio of 3.32 and a beta of 0.38.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a positive return on equity of 5.38% and a negative net margin of 0.12%. During the same period last year, the firm posted $0.19 earnings per share. The company's revenue for the quarter was down 22.6% compared to the same quarter last year. As a group, analysts forecast that Cross Country Healthcare, Inc. will post 0.53 EPS for the current year.
Wall Street Analyst Weigh In
CCRN has been the subject of a number of research reports. Wall Street Zen initiated coverage on Cross Country Healthcare in a research report on Thursday, May 15th. They set a "hold" rating for the company. JMP Securities reaffirmed a "market perform" rating on shares of Cross Country Healthcare in a research report on Thursday, February 6th. Barrington Research reaffirmed a "market perform" rating and set a $18.61 price target on shares of Cross Country Healthcare in a research report on Friday, March 14th. Finally, UBS Group lowered their price target on Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating for the company in a research report on Tuesday, May 13th. Seven investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $17.93.
Check Out Our Latest Report on CCRN
Cross Country Healthcare Company Profile
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
